Health ❯ Healthcare

Chronic Conditions

Diabetes Obesity Heart Disease Hypertension Type 2 Diabetes Asthma Diabetes Management Cardiovascular Health Heart Failure Comorbidities

GLP-1 Weight-Loss Boom Triggers Safety Warnings and New Oversight

Experts warn many users lack nutrition support, raising risks of deficiencies, muscle loss and disordered eating.

FDA Recalls Specific FreeStyle Libre 3 Sensors Over Faulty Low-Glucose Readings

JAMA Finds Nearly Half of U.S. Adults Have Hypertension, Most Uncontrolled

KFF Poll Finds Prior Authorization Is Top Non‑Cost Barrier to Care for Insured Americans

Roche’s CT-388 Shows Up to 22.5% Placebo-Adjusted Weight Loss in Phase 2 as Phase 3 Nears

Apple Expands Apple Watch Hypertension Alerts to Australia, Brazil, South Korea and More

Wegovy Pill Debuts to Strong U.S. Demand as Next‑Gen Obesity Drugs Near Decisions

After-Meal Blood Sugar Spikes Tied to 69% Higher Alzheimer’s Risk, Large Genetic Study Finds

California Study Finds Sharp Differences in Pregnancy Hypertension Risk Across Asian American, Native Hawaiian and Pacific Islander Subgroups

BMJ Review Flags Rapid Weight Regain After GLP‑1 Stop as UK Approves Higher‑Dose Wegovy

Oxford Review Finds GLP-1 Weight Loss Largely Lost Within About Two Years After Stopping

Weight Returns Quickly After Stopping GLP-1 Drugs, Oxford Review Finds

Alumis TYK2 Pill Hits Phase 3 Goals in Psoriasis as Stock Jumps and $175 Million Offering Is Planned

CMS Sets ACCESS Model Deadlines for July Launch of Outcome-Based Chronic Care

NHS England Names Nine Conditions for NHS Online Launch in 2027

NHS Reissues Methotrexate Safety Guidance on When to Call 111 or 999

Trump Says He Takes 325 mg Aspirin Daily, Rejects Advice to Lower Dose

States Curb Medicaid Coverage as First GLP‑1 Weight‑Loss Pill Debuts and Cash Prices Fall

NHS Guidance on Beclometasone Inhalers Reiterated, Flagging Age Limits and Trace Alcohol in Some Brands

Manchester Woman Says Long-Term Depo Shots Led to Major Tooth Loss, Seeks Implant Funding